Complement Inhibitors for Treatment of Geographic Atrophy and Advanced Nonexudative AMD

Potential exists to slow or prevent disease progression.

Private Equity Update for Retinal Physicians

Take careful consideration before deciding to move forward.

Roche to Get Foothold in Gene Therapy With Acquisition of Spark

The Mechanism of the Bispecific Antibody Faricimab

Targeting VEGF-A and Ang2 has effect greater than targeting either alone.

Retinal Gene Therapies in Clinical Trials

A proliferation of clinical trials means hope for patients.

Gene Therapy Implications for Retina Specialists

Evolving endpoints, novel orphan disease treatment paradigms, and the dawn of precision medicine.

The Port Delivery System With Ranibizumab

A new treatment strategy for patients with nAMD enters a phase 3 clinical trial.

Prefilled Syringe Delivery of Intravitreal Anti-VEGF Medications

Advantages for patients and physicians.

UPFRONT: The Upsurge in Gene Therapy Trials

SUBSPECIALTY NEWS: Angiogenesis meeting highlights, elevated IOP after intravitreal injection, and more.

By Rehan M. Hussain, MD

FUTURE FILE: Early data on promising new treatments for retinal disease.

Highlighting innovative early-stage and preclinical concepts in retina

CODING Q&A: Challenges in Remote Screening of Diabetic Patients

Part 1 of 2: patient care and reimbursement.

CLINICAL TRIAL DOWNLOAD: Two-Year Brolucizumab Data

Results reinforce the drug’s potential.

RETINA CONVERSATIONS: A Conversation With Evangelos S. Gragoudas, MD

Ocular cancer, angiogenesis, PDT, and more.

NEW PRODUCT APPLICATIONS: The Newest Frontier in Microperimetry

CenterVue’s intuitive MAIA can track a variety of macular pathologies.

CLINICAL TRIAL UPDATE